Biocon chief Kiran Mazumdar-Shaw says that the research division is set to benefit from the fall in the value of rupee. "That apart, Biocon will see margin improvement in exports due to the rate differential," she says.
first published: Sep 14, 2011 12:04 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

